Basic Information
Memantine Accord
Regulatory Information
EMEA/H/C/002766
Authorised
December 3, 2013
September 18, 2013
7
January 12, 2022
Company Information
Spain
Edificio Este Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona
ACCORD HEALTHCARE SL
Drug Classification
Generic Medicine
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of patients with moderate to severe Alzheimer’s disease.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Memantine Accord. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Memantine Accord. For practical information about using Memantine Accord, patients should read the package leaflet or contact their doctor or pharmacist.